IMVT
Immunovant, Inc. · Healthcare
Chief Development Officer Julia G. Butchko sold $50K of Immunovant, Inc.
Sold$50,051
$38.59Price
1,297Shares
What IMVT did after the filing
- The stock from Tue, Jan 9 close, $43.79
- −17.8%
- S&P 500, same days
- +7.1%
Measured over 30 trading days, to the Feb 22 close.
Traded Fri, Jan 5. Filed Tue, Jan 9, 11:20 AM ET, during the session. Returns use the Jan 9 close and the Feb 22 close. Not investment advice.